Assessing the impact of a symptom-based mass screening and testing intervention during a novel infectious disease outbreak: The case of COVID-19

Yang Ge, Brian Kenneth McKay, Shengzhi Sun, Feng Zhang, Andreas Handel
doi: https://doi.org/10.1101/2020.02.20.20025973

Article Information

doi 
https://doi.org/10.1101/2020.02.20.20025973
History 
  • April 15, 2020.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Yang Ge1,*,
  2. Brian Kenneth McKay1,
  3. Shengzhi Sun2,
  4. Feng Zhang3 and
  5. Andreas Handel1,*
  1. 1Department of Epidemiology and Biostatistics, The University of Georgia, Athens, GA, USA
  2. 2Department of Environmental Health, Boston University School of Public Health, Boston, MA, USA
  3. 3Department of Biostatistics and Data Science, University of Texas Health Science Center at Houston, School of Public Health, Houston, TX, USA
  1. ↵*Corresponding author: Yang Ge, Andreas Handel, Corresponding author email: yang.ge{at}uga.edu, ahandel{at}uga.edu
Back to top
Posted April 15, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Assessing the impact of a symptom-based mass screening and testing intervention during a novel infectious disease outbreak: The case of COVID-19
Yang Ge, Brian Kenneth McKay, Shengzhi Sun, Feng Zhang, Andreas Handel
medRxiv 2020.02.20.20025973; doi: https://doi.org/10.1101/2020.02.20.20025973
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area